National Liver Cancer Biomarker Screening Trial

Conditions: Carcinoma, Hepatocellular; Liver Cancer; Liver Cirrhosis; Hepatitis B Interventions: Diagnostic Test: GALAD; Diagnostic Test: Liver Ultrasound with or without AFP Sponsors: University of Texas Southwestern Medical Center; National Cancer Institute (NCI); University of Pennsylvania; University of Michigan; Dana-Farber Cancer Institute; Baylor College of Medicine; Fred Hutchinson Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials